The latest announcement is out from Autonomix Medical, Inc. (AMIX).
Autonomix Medical, Inc. has secured a license agreement with RF Innovations, Inc. to use their intellectual property for the Apex 6 Radiofrequency Generator, an FDA-cleared pain management technology. Expected to be finalized by the end of July 2024, the deal grants Autonomix a non-exclusive, royalty-free license, excluding the sale for spine pain treatment, and includes the issuance of 250,000 common stock shares to RFI. The license may be terminated if Autonomix breaches the agreement or encounters bankruptcy, with the terms detailed further in the company’s recent Form 8-K filing and press release.
For detailed information about AMIX stock, go to TipRanks’ Stock Analysis page.
